Dr. Horacio Bach – receives major grant from CIHR for COVID-19 antibody development

dr horacio bach receives major grant from cihr for covid 19 anitbody development
dr horacio bach corona virus research

An amazing show  of public support for UBC disease researcher Dr. Horciao Bach, who has started his COVID-19 antibody development project.  Dr. Horacio Bach is one of BioMark’s scientific advisors and is expert on antibody engineering.  He has received a major grant from CIHR for COVID- 19 antibody development.

More information can be found at @DiseasesUbc

Share this post:
Share on facebook
Share on twitter
Share on linkedin
Share on email
Categories
Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.
CSE: BUX
OTC: BMKDF
FSE: 20B
Investors

Related articles ...

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.